Share of the population living with HIV receiving antiretroviral therapy in Luxembourg

Luxembourg: Share of the population living with HIV receiving antiretroviral therapy was 83.8% in 2024. ◆ Volatile

Latest (2024)
83.8%
Change on year
up 1.4%
World rank
43rd
of 149 countries
All-time high
83.8%
in 2024
All-time low
0.0%
in 1990
Years of data
35
1990–2024

Share of the population living with HIV receiving antiretroviral therapy in Luxembourg, 1990–2024

0204060801990200720241990: 0 %1991: 0 %1992: 0 %1993: 0 %1994: 0 %1995: 14.2 %1996: 21.6 %1997: 31.6 %1998: 35 %1999: 37.8 %2000: 39.9 %2001: 40.8 %2002: 42.2 %2003: 41 %2004: 41.5 %2005: 44.9 %2006: 47.9 %2007: 46.6 %2008: 49.5 %2009: 50.9 %2010: 53.1 %2011: 56.1 %2012: 59.3 %2013: 59.4 %2014: 64.3 %2015: 65.9 %2016: 67.8 %2017: 70 %2018: 70.3 %2019: 71.4 %2020: 71.6 %2021: 74.9 %2022: 82.3 %2023: 82.6 %2024: 83.8 %

Source: Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Measured in %.

Analysis

In 2024, share of the population living with hiv receiving antiretroviral therapy in Luxembourg stood at 83.8%. That is the highest value across all 35 years on record.

That represents a change of up 1.4% on the previous year and up 30.3% over ten years.

Over the whole period, share of the population living with hiv receiving antiretroviral therapy in Luxembourg peaked at 83.8% in 2024 and was at its lowest, 0.0%, in 1990.

That places Luxembourg 43rd out of 149 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Share of the population living with HIV receiving antiretroviral therapy in Luxembourg, year by year

Annual values for Share of the population living with HIV receiving antiretroviral therapy in Luxembourg, 1990 to 2024.
Year % Change
1990 0.0% —
1991 0.0% —
1992 0.0% —
1993 0.0% —
1994 0.0% —
1995 14.2% —
1996 21.6% +52.3%
1997 31.6% +46.4%
1998 35.0% +10.6%
1999 37.8% +8.1%
2000 39.9% +5.7%
2001 40.8% +2.2%
2002 42.2% +3.3%
2003 41.0% -2.8%
2004 41.5% +1.3%
2005 44.9% +8.0%
2006 47.9% +6.7%
2007 46.6% -2.7%
2008 49.5% +6.3%
2009 50.9% +2.9%
2010 53.1% +4.3%
2011 56.1% +5.5%
2012 59.3% +5.8%
2013 59.4% +0.1%
2014 64.3% +8.3%
2015 65.9% +2.5%
2016 67.8% +2.8%
2017 70.0% +3.3%
2018 70.3% +0.5%
2019 71.4% +1.5%
2020 71.6% +0.3%
2021 74.9% +4.5%
2022 82.3% +10.0%
2023 82.6% +0.4%
2024 83.8% +1.4%

Luxembourg compared with similar countries

  • Luxembourg's 83.8% is above the median for high income countries, which is 79.3%, 1.1× the median. (42 countries reporting)
  • Luxembourg's 83.8% is above the median for Europe & Central Asia, which is 82.9%, 1.0× the median. (34 countries reporting)

Biggest year-on-year movements

Years where Share of the population living with HIV receiving antiretroviral therapy in Luxembourg changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
1996 +52.3% 14.2% 21.6%
1997 +46.4% 21.6% 31.6%

Averages by decade

DecadeAverage LowestHighest Years
1990s 14.0% 0.0% 37.8% 10
2000s 44.5% 39.9% 50.9% 10
2010s 63.8% 53.1% 71.4% 10
2020s 79.0% 71.6% 83.8% 5

Countries ranked near Luxembourg

  1. 40 Uganda 84.7% compare
  2. 41 New Zealand 84.2% compare
  3. 42 Comoros 84.1% compare
  4. 44 Nigeria 83.3% compare
  5. 45 Ecuador 82.1% compare
  6. 46 Burkina Faso 82.0% compare

See the full ranking of 149 places →

More reference data data for Luxembourg

All data for Luxembourg →

Frequently asked questions

What is share of the population living with hiv receiving antiretroviral therapy in Luxembourg?
Share of the population living with hiv receiving antiretroviral therapy in Luxembourg was 83.8% in 2024, according to Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data.
What is the highest share of the population living with hiv receiving antiretroviral therapy recorded in Luxembourg?
The highest recorded value was 83.8% in 2024.
What is the lowest share of the population living with hiv receiving antiretroviral therapy recorded in Luxembourg?
The lowest recorded value was 0.0% in 1990.
How does Luxembourg rank for share of the population living with hiv receiving antiretroviral therapy?
Luxembourg ranks 43rd out of 149 countries with data for 2024.
Is share of the population living with hiv receiving antiretroviral therapy rising or falling in Luxembourg?
Over the last ten years it is up 30.3%. The long-run trend across the full record is volatile.
Where does this Luxembourg data come from?
The figures come from Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as part of Share of the population living with HIV receiving antiretroviral therapy. Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 35 observations, free to reuse under CC BY 4.0 (Our World in Data).

Share, cite or embed this page

Cite this page

Share of the population living with HIV receiving antiretroviral therapy in Luxembourg. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data. Retrieved 29 September 2026, from https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/luxembourg/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://reference.statizoid.com/stat/gap-to-reaching-the-target-of-art/luxembourg/">Share of the population living with HIV receiving antiretroviral therapy in Luxembourg</a> — Statizoid

About this data

Indicator
Share of the population living with HIV receiving antiretroviral therapy
Unit
%
Source
Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
149 places, 5,062 data points, 1990–2024
Last refreshed

Percentage of individuals diagnosed with HIV who are currently receiving antiretroviral therapy. This is the central estimate.